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As Th17 cell developmental requirements continue to be studied, Gutcher et al. (2011) demonstrate in this
issue of Immunity that autocrine TGF-b cytokine promotes Th17 cell development and maintenance.The initial description of T helper 17 (Th17)
cells depicted a CD4+ effector T cell that
produced primarily IL-17 and whose
development was inhibited by the cyto-
kines IFN-g and IL-4 (Harrington et al.,
2005; Park et al., 2005). Delving further
into defining the requirements for Th17
cell development, researchers consid-
ered the cytokine TGF-b, because it had
been shown previously to repress IFN-g
expression and to potently inhibit Th1
and Th2 cell differentiation through the
suppression of the transcription factors
T-bet and GATA3. Not surprisingly,
reports demonstrating the role of TGF-b
in Th17 cell development, specifically in
the presence of IL-6, followed shortly
thereafter. However, in a rare case where
the mouse immune system appeared not
to mirror its more evolved counterpart,
human Th17 cells were initially shown to
develop in the absence of TGF-b,
requiring only IL-6 and IL-1b or IL-23
and IL-b (Acosta-Rodriguez et al., 2007;
Wilson et al., 2007). Later studies refuted
these observations, demonstrating
a requirement for TGF-b in the develop-
ment of Th17 cells from painstakingly
isolated naive CD4+ T cells in medium
lacking serum, an oft and heretofore
ignored source of varying amounts of
TGF-b (Korn et al., 2009). Although the
role of TGF-b in induced regulatory T
(Treg) cell generation is widely accepted,
considerable controversy regarding the
requirement of TGF-b in directing Th17
cell development remains, and two recent
works published in Nature (Ghoreschi
et al., 2010) and here, in the current issue
of Immunity (Gutcher et al., 2011),
continue to add fuel to the fire.
Building on their previous study (Li et al.,
2007) that showed T cells are the main
source of TGF-b responsible for driving
Th17 cell development, Gutcher et al.288 Immunity 34, March 25, 2011 ª2011 Else(2011) further dissects the T cell popula-
tions responsible for TGF-b-driven Th17
cell differentiation. The current study
begins by demonstrating that all progeny
of naive CD4+ T cells have the potential
to express TGF-b, but which of these cells
are the primary source of TGF-b involved
in Th17 cell development? To address
this question, Gutcher et al. (2011) took
advantage of the preferential expression
of OX-40 in activated CD4+ T cells and
Treg cells and used an OX-40-driving Cre
recombinase-expressing mouse strain to
successfully delete Tgfb1 in the majority
of these cells, designating the resultant
mice Tgfb1f/n Tnfrsf4-cre. In comparison
to Tgfb1f/n Cd4-cre mice with deletion of
TGF-b in all T cells (Li et al., 2007),
Tgfb1f/n Tnfrsf4-cre animals developed
a much less severe wasting disease and
did not exhibit signs of spontaneous acti-
vation and differentiation in the periphery.
Consequently, TGF-b deletion in the
periphery was confined mainly to the
Treg cell population, present in increased
frequencies in these mice, thereby impli-
cating Treg cell-derived TGF-b as a critical
requirement of Treg cell maintenance. In
the gut, though, there is a higher preva-
lence of activated T cells than in the
periphery (Ivanov et al., 2008) and there-
fore the reduced percentages of gut-resi-
dent IL-17-expressing cells in Tgfb1f/n
Tnfrsf4-cre mice along with their resis-
tance to developing experimental autoim-
mune encephalomyelitis (EAE), resulting
from decreased IL-17+ cells in the central
nervous system (CNS), hinted that acti-
vated T cells supply TGF-b needed for
optimal Th17 cell development.
By utilizing a Foxp3-driving Cre recom-
binase to delete Tgfb1 in regulatory cells
(designated Tgfb1f/n Foxp3-cre), Gutcher
et al. (2011) demonstrated that these
animals remained healthy, without signsvier Inc.of inflammatory disease or spontaneous
T cell activation; however, increases in
frequencies and numbers of Foxp3+ cells
in peripheral andmesenteric lymph nodes
were observed, thereby confirming Treg
cells as the source of TGF-b responsible
for limiting their own proliferation. Induc-
tion of EAE in Tgfb1f/n Foxp3-cre mice
resulted in the development of IL-17+ cells
in theCNSwith associated disease symp-
toms similar to that of wild-type mice,
demonstrating that Treg cell-derived
TGF-b is insufficient to direct Th17 cell
development, yet a role for Treg cells in
promoting Th17 cell differentiation
remains plausible. Studies by Chen et al.
(2011) and Pandiyan et al. (2011) in this
issue of Immunity report that Treg cells
promote Th17 cell development by
consuming the Th17 cell-prohibitive cyto-
kine, IL-2, early in Th17 cell differentiation,
which simultaneously promotes their
own growth and proliferation, thereby
allowing for a suppressive role later in
the response.
The elimination of Treg cells as the
source of Th17 cell-inducing TGF-b left
activated T cells as likely suspects but
which members of this heterogeneous
population are key? By using a TGF-b
reporter mouse line, Gutcher et al. (2011)
determined that in vitro polarized Th1,
Th2, and Th17 cells all can express
TGF-b, but it is most highly expressed in
Th17 cells. Further, induction of EAE in
Rag1/mice reconstituted with an equal
mix of wild-type and Tgfb1f/n Cd4-cre
bone marrow resulted in wild-type
derived Th17 and Th1 cells in the CNS
whereas substantially fewer IL-17+ cells
originating from the CD4+ Tgfb1-deficient
bone marrow were detected, elegantly
establishing that TGF-b acts in an auto-
crine manner to promote Th17 cell
differentiation.
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Figure 1. Proposed Th17 and Treg Cell Developmental Pathways
Naive CD4+ T cells (green circles) in the presence of high concentrations of TGF-b and retinoic acid
develop into regulatory T cells that produce autocrine TGF-b, instrumental in maintaining their develop-
ment (orange circles). Lower concentration of TGF-b together with IL-6 and IL-1b promote the develop-
ment of Th17 cells (blue circles) expressing autocrine TGF-b and IL-21, further reinforcing their own
development. In the presence of IL-12, these cells can be diverted to cells expressing both IFN-g and
IL-17 (red cells). The Th17 cell-inhibiting cytokine IL-2 is also expressed but is consumed by Treg cells,
promoting both Th17 cell development and Treg cell survival. In the absence of TGF-b, IL-6, IL-1b, and
IL-23 together drive the development of Th17 cells with a pathogenic phenotype (red circles).
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confirm and extend previous observa-
tions that T cell-derived TGF-b is required
for Th17 cell differentiation, adding the
unforeseen finding that Th17 cell-
produced TGF-b is essential for reinforc-
ing their own maintenance. Recently,
however, Ghoreschi et al. (2010) demon-
strated that Th17 cells can arise in the
absence of TGF-b signaling, a seemingly
contradictory finding to that of Gutcher
et al. (2011). Similar to the initial reports
describing the generation of human
Th17 cells, Ghoreschi et al. (2010) demon-
strated that IL-17+ T cells can be gener-
ated from mouse naive CD4+ T cells with
solely IL-6, IL-23, and IL-1b, though
significantly fewer IL-17+ cells arise in
comparison to TGF-b plus IL-6-generated
cells and those cells that do develop
possess a more pathogenic phenotype
than do TGF-b-derived cells.
Ghoreschi et al. (2010) find that Th17
cells differentiated with TGF-b express
the regulatory cytokines IL-9 and IL-10whereas those derived without TGF-b
express Th1 cell-associated molecules
including IFN-g and migrate to inflamma-
tory sites. By using a transfer model of
EAE, Ghoreschi et al. (2010) demonstrate
that Th17 cells polarized without TGF-b
induce a more severe disease and
have greater numbers of IL-17+IFN-g+
cells in the CNS compared to mice
receiving TGF-b-directed Th17 cells. In
normal mice, MOG peptide-induced EAE
results in substantial numbers of
CD4+IFN-g+IL-17+ T cells in the CNS,
but whether these double-positive cells
are derived from a TGF-b-independent
pathway is unclear.
In the continued presence of TGF-b
alone, Th17 cells can develop into cells
expressing both IL-17 and IFN-g, demon-
strating an intrinsic property of Th17 cells
to deviate to a cell that has Th1 cell-like
characteristics (Lee et al., 2009). That
Th17 cells can rapidly respond to IL-12
signaling by upregulating IFN-g further
emphasizes this property. It is thereforeImmunity 3not entirely unexpected that cells gener-
ated in the absence of TGF-b express
IFN-g. However, because TGF-b is widely
expressed, it is difficult to imagine
a scenario where a tissue would be
completely devoid of its expression, yet
it is conceivable that limiting amounts in
a cell’s immediate vicinity would have an
impact on its fate, because low concen-
trations of TGF-b appear to favor Th17
cell development. Ghoreschi et al. (2010)
suggest that Th17 cells are derived from
both TGF-b-dependent and -independent
pathways, but an alternative and not
mutually exclusive explanation is that the
inherent plasticity of Th17 cells is ampli-
fied in conditions where high concentra-
tions of inflammatory cytokines and
limiting TGF-b tip the balance to a more
aggressive phenotype (Figure 1). Never-
theless, reconciling Ghoreschi et al.
(2010)’s observations with the fact that
Th17 cells fail to develop in the absence
of T cell-derived TGF-b in the EAE model
is somewhat problematic and further
complicated by the revelation that Th17
cells themselves can express TGF-b, but
perhaps the ability to generate appro-
priate IL-1b, IL-6, and IL-23 signals in
the specific contextual environment of
a naive CD4+ T cell is dysregulated in
the Tgfb1f/n Cd4-cre mouse model,
though this remains to be determined.
There appears to be little disagreement
that Th17 cells can be generated from
naive CD4+ T cells in the presence of
TGF-b and IL-6, and the studies of both
Gutcher et al. (2011) and Ghoreschi et al.
(2010) reaffirm this tenet. However, the
role of autocrine TGF-b in promoting
Th17 cell development at steady state
requires further investigation, particularly
in regards to the signals that drive a Th17
cell to produce TGF-b. The combination
of IL-6, IL-23, and IL-1b was largely ineffi-
cient in this respect because the addition
of neutralizing TGF-b antibodies did not
effect Th17 cell development. Though
considerable debate continues regarding
the critical factors necessary for Th17
cell development, the varied environ-
mental conditions in which they develop
suggests a complex array of context-
specific signals rather than absolute
requirements. Thus, future studies
focusing on the contextual and environ-
mental requirements for Th17 cell genera-
tion both at steady state and during
inflammatory conditions are needed.4, March 25, 2011 ª2011 Elsevier Inc. 289
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In this issueof Immunity, Hall et al. (2011) showthat vitaminAand itsmetabolitesplayacentral role in regulating
adaptive immunity by promoting the development of both inflammatory and regulatory T cell responses.VitaminA isanessential fat-solublenutrient
that is required for the development of
many organs and tissues. It is converted
into several metabolically active deriva-
tives, including retinoic acid (RA). RA is
a potent regulatory molecule that controls
gene expression through RA receptors
(RARs), members of the nuclear hormone
receptor family that activate the transcrip-
tion of specific target genes. The RA-RAR
signaling machinery represents an evolu-
tionarily ancient gene regulatory pathway,
which is conserved in all vertebrates and
invertebrate chordates. It appears to have
evolved as a core regulatory network that
governs cell fate specification during
developmental patterning. In vertebrates,
RA also plays important roles in the devel-
opment of specific immunity, directing
immunoglobulin class switching in B cells
and inducing gut homing receptors on B
and T lymphocytes. However, until rela-
tively recently there was little known about
how RA impacts T cell development.
In 2007, a raft of landmark papers from
several laboratories revealed a critical rolefor RA in directing intestinal CD4+ T cell
development (Benson et al., 2007;
Coombes et al., 2007; Denning et al.,
2007; Mucida et al., 2007; Sun et al.,
2007). According to these initial studies,
this effect was restricted to a particular
subset of CD4+ T cells. CD4+ T cells can
develop along one of several distinct path-
ways that dictate the type of immune
response that ensues. T helper type 1
(Th1) and Th17 cell developmental subsets
are associated with aggressive proinflam-
matory responses to infection, whereas T
regulatory (Treg) cells constitute a distinct
developmental subset that is associated
with immune responses that prevent or
dampen inflammation. Each of the studies
from 2007 showed that RA signaling trig-
gered intestinal Treg cell development.
A specific subset of intestinal dendritic cells
(DCs) produced RA, which synergized with
thecytokineTGF-b to induceFoxp3 innaive
CD4+ T cells, promoting differentiation
along the Treg cell pathway (Coombes
et al., 2007; Sun et al., 2007). At the same
time, other studies revealed that RA in-hibited Th17 cell development, leading to
the idea of RA as an anti-inflammatory
factor that promotes intestinal Treg cell
differentiation at the expense of Th17 cell
development (Elias et al., 2008; Mucida
et al., 2007).
In this issue of Immunity, Hall et al. (2011)
challenge the idea thatRA is ananti-inflam-
matory factor that restricts T cell differenti-
ation to the Treg cell pathway. Instead, the
authors show that RA plays a much
broader role in controlling CD4+ T cell fate
(Figure 1). To investigate the role of vitamin
A and its metabolites in CD4+ T cell
responses during infection, Hall et al. put
mice on a diet lacking vitamin A. They
then provoked inflammation by using
Toxoplasma gondii, an intracellular proto-
zoan parasite that normally enters the
body through the gastrointestinal tract,
eliciting robust mucosal inflammation and
a strong systemic Th1 cell response.
When Hall et al. examined CD4+ T cells
after oral infection with T. gondii, they
observed thatmiceonavitaminA-deficient
diet had a marked reduction in Th1 cell
